IL18 and hepatocellular carcinoma: Indeed, numerous case-control studies12, 13, 14, 15, 16, 17, 18, 19 have investigated whether polymorphisms at position -137 (rs187238) and -607 (rs1946518) within the IL-18 promoter influence risk of HCC.